Author Correction: Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Guardado en:
Autores principales: | Elba Pascual-Goñi, Lorena Martín-Aguilar, Cinta Lleixà, Laura Martínez-Martínez, Manuel J. Simón-Talero, Jordi Díaz-Manera, Elena Cortés-Vicente, Ricard Rojas-García, Esther Moga, Cándido Juárez, Isabel Illa, Luis Querol |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1114d10cbb6644b9bbac88322d56bd12 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Optimization of workflow and screening panels for the detection of malignant monoclonal gammopathies
por: Oliveros Conejero Raquel, et al.
Publicado: (2020) -
Diffuse normolipemic plane xanthoma associated with monoclonal gammopathy
por: Yoon K. Cohen, et al.
Publicado: (2015) -
Coexistence of Prefibrotic Myelofibrosis with Monoclonal Gammopathy of Undetermined Significance: A Case Report
por: Omar M. Ismail, et al.
Publicado: (2021) -
Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study
por: Saemundur Rognvaldsson, et al.
Publicado: (2021) -
Monoclonal gammopathy of undetermined significance is associated with prostate cancer in a population-based cohort study
por: Nicola Hornung, et al.
Publicado: (2021)